Bio-Techne (TECH) Accumulated Expenses (2010 - 2026)

Bio-Techne's Accumulated Expenses history runs 17 years deep, the most recent figure standing at $17.7 million for Q1 2026.

• On a quarterly basis, Accumulated Expenses fell 26.03% year-over-year to $17.7 million in Q1 2026; TTM through Mar 2026 was $17.7 million, a 26.03% decrease from a year earlier, with the FY2025 full-year figure at $25.7 million, up 3.12% from the prior year.
• Accumulated Expenses fell to $17.7 million in Q1 2026 per TECH's latest filing, from $45.0 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $62.0 million in Q2 2022 and bottomed at $13.8 million in Q3 2022.
• The 5-year median for Accumulated Expenses is $25.7 million (2025), against an average of $30.2 million.
• Across the five-year window, Accumulated Expenses slumped 75.98% in 2023 and jumped 183.31% in 2024, its largest moves.
• Year by year, Accumulated Expenses stood at $28.6 million in 2022, then increased by 15.23% to $33.0 million in 2023, then dropped by 16.52% to $27.5 million in 2024, then surged by 63.48% to $45.0 million in 2025, then tumbled by 60.73% to $17.7 million in 2026.
• Per Business Quant, the three latest TECH Accumulated Expenses figures stand at $17.7 million (Q1 2026), $45.0 million (Q4 2025), and $43.6 million (Q3 2025).